In certain instances, once drug exposure (e.g., concentration in the perilymph) of a drug reaches steady state, the concentration of the drug in the perilymph stays at or about the therapeutic dose for an extended period of time (e.g., one day, 2 days, 3 days, 4 days, 5 days, 6 days, 1 week, 2 weeks, 1 month, or 6 months)
Recommended Dosage and Administration of BPC-157 Since BPC-157 is not FDA-approved, there are no official dosing standards
Since this practice started vitamin K deficiency disease is almost unheard of
Melanocortin Receptor Pharmacology mapping of truncated -MSH analog effects on localized anti-inflammatory responses
Bioengineered 13, 19211930
Blick might also order a urine test, a voiding study, a cystoscopy (look into the bladder) or a prostate-specific antigen (PSA) test